CD40 and neoplasm: In both the METABRIC and TCGA datasets, downregulation of genes such as CD4 and CD40 may indicate decreased CD4+ T cell response or decreased CD40-mediated apoptosis, both of which are correlated with tumor regression, better response to therapy, and higher overall breast cancer survival [65, 66].